Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1961 1
1969 1
1970 2
1971 3
1972 2
1973 4
1974 4
1975 10
1976 6
1977 4
1978 9
1979 3
1980 7
1981 4
1982 3
1983 3
1984 4
1985 9
1986 11
1987 15
1988 6
1989 10
1990 13
1991 15
1992 24
1993 29
1994 24
1995 26
1996 52
1997 56
1998 79
1999 111
2000 140
2001 172
2002 228
2003 304
2004 315
2005 418
2006 497
2007 580
2008 663
2009 712
2010 839
2011 950
2012 1079
2013 1117
2014 1254
2015 1321
2016 1339
2017 1441
2018 1470
2019 1396
2020 1663
2021 1643
2022 1518
2023 1510
2024 620

Text availability

Article attribute

Article type

Publication date

Search Results

20,862 results

Results by year

Filters applied: . Clear all
Page 1
Safety and efficacy of inebilizumab for the treatment of neuromyelitis optica spectrum disorder: end-of-study results from the open-label period of the N-MOmentum trial.
Cree BAC, Kim HJ, Weinshenker BG, Pittock SJ, Wingerchuk DM, Fujihara K, Paul F, Cutter GR, Marignier R, Green AJ, Aktas O, Hartung HP, She D, Rees W, Smith M, Cimbora D, Katz E, Bennett JL; N-MOmentum study investigators. Cree BAC, et al. Among authors: kim hj. Lancet Neurol. 2024 Jun;23(6):588-602. doi: 10.1016/S1474-4422(24)00077-2. Lancet Neurol. 2024. PMID: 38760098 Clinical Trial.
Characterization of HER2-low breast cancer in young women with germline BRCA1/2 pathogenetic variants: Results of a large international retrospective cohort study.
Schettini F, Blondeaux E, Molinelli C, Bas R, Kim HJ, Di Meglio A, Bernstein Molho R, Linn SC, Pogoda K, Carrasco E, Punie K, Agostinetto E, Lopetegui-Lia N, Phillips KA, Toss A, Rousset-Jablonski C, Acheritogaray M, Ferrari A, Paluch-Shimon S, Fruscio R, Cui W, Wong SM, Vernieri C, Dieci MV, Matikas A, Rozenblit M, Villarreal-Garza C, De Marchis L, Puglisi F, Vasconcelos de Matos L, Mariño M, Teixeira L, Graffeo R, Rognone A, Chirco A, Antone N, Abdou Y, Marhold M, Božović-Spasojević I, Cortés Salgado A, Carmisciano L, Bruzzone M, Curigliano G, Prat A, Lambertini M. Schettini F, et al. Among authors: kim hj. Cancer. 2024 May 16. doi: 10.1002/cncr.35323. Online ahead of print. Cancer. 2024. PMID: 38752572
SARS-CoV-2 infection exacerbates the cellular pathology of Parkinson's disease in human dopaminergic neurons and a mouse model.
Lee B, Choi HN, Che YH, Ko M, Seong HM, Jo MG, Kim SH, Song C, Yoon S, Choi J, Kim JH, Kim M, Lee MY, Park SW, Kim HJ, Kim SJ, Moon DS, Lee S, Park JH, Yeo SG, Everson RG, Kim YJ, Hong KW, Roh IS, Lyoo KS, Kim YJ, Yun SP. Lee B, et al. Among authors: kim hj. Cell Rep Med. 2024 May 10:101570. doi: 10.1016/j.xcrm.2024.101570. Online ahead of print. Cell Rep Med. 2024. PMID: 38749422 Free article.
20,862 results
You have reached the last available page of results. Please see the User Guide for more information.